Approach to chronic cough and its management

Reading File

Finding Sources

Searching PubMed

"chronic cough" AND management

Reading File

I now have comprehensive coverage from three major textbooks. Let me compile the full, well-structured answer.

Approach to Chronic Cough and Its Management

Definition and Classification by Duration

Cough is classified by duration into three categories:

Type	Duration	Common Causes
Acute	< 3 weeks	URTI, aspiration, inhalation of noxious chemicals/smoke
Subacute	3-8 weeks	Post-infectious (post-viral tussive syndrome, pertussis)
Chronic	> 8 weeks	Wide range - see below

Chronic cough is defined as cough lasting more than 8 weeks and represents a significant clinical and quality-of-life burden.

Common Causes of Chronic Cough

The five most common causes in patients with a normal chest radiograph are:

Smoking / Chronic Bronchitis - typically worse in the morning, productive
Upper Airway Cough Syndrome (UACS) - formerly "postnasal drip syndrome" - associated with mucus drainage, allergy/sinus history, throat clearing
Asthma / Cough-Variant Asthma - worse at night, exacerbated by irritants, episodic wheezing and dyspnea
Gastroesophageal Reflux Disease (GERD) - worse when lying down, associated heartburn, improves with anti-acid therapy
ACE Inhibitor / ARB-induced cough - occurs in 5-30% of ACE inhibitor users; not dose-dependent

These conditions, alone or in combination, account for the vast majority of cases with a normal or non-contributory chest X-ray. However, strict adherence to this "short list" should not discourage a broader search.

Less Common but Important Causes

Eosinophilic bronchitis (non-asthmatic)
Bronchiectasis
Chronic aspiration
Interstitial lung disease (e.g., IPF)
Sarcoidosis, vasculitis
Bronchogenic or metastatic carcinoma
Left ventricular failure
Obstructive sleep apnea (OSA)
Psychogenic/habit cough (especially in children)
Tuberculosis (in endemic regions - always consider)
Vascular rings, foreign body, tracheobronchomalacia (pediatric)

Pathophysiology: Cough Hypersensitivity Syndrome

In recent years, a distinct "cough hypersensitivity syndrome" has emerged as a recognized entity - characterized by sensitized sensory nerve endings and afferent neural pathways, akin to chronic neuropathic pain. Key features:

Dry or minimally productive cough
Tickle or sensitivity in the throat
Triggered by talking, laughing, laughing, exercise, temperature changes, perfumes, smoke
More common in women aged 50-70, often with onset around menopause
Associated with enhanced cough reflex to capsaicin or citric acid
Mucosal biopsies show: increased mast cells, sub-basement membrane thickening, increased TRPV1 expression, elevated calcitonin gene-related peptide
Diagnosis by exclusion after ruling out other causes

Up to 46% of chronic cough may be ultimately classified as idiopathic or refractory - Murray & Nadel's Textbook of Respiratory Medicine

ACE Inhibitor Cough - Key Points

Incidence: 5-30% (Harrison's); ~5-10% in Western populations (Tintinalli's)
Not dose-dependent
Mechanism: ACE blockade causes accumulation of bradykinin and substance P, stimulating pulmonary cough receptors and promoting irritating prostaglandin metabolites
Onset: highly variable - as early as 1 week to as late as 1 year after starting the drug
Any patient with unexplained chronic cough on an ACE inhibitor should have a trial off the medication regardless of timing of cough onset relative to drug start
Cough resolves within 1-4 weeks of stopping (may linger up to 3 months)
ARBs do NOT cause cough and are a safe alternative
Failure to see cough decrease after 1 month off medication argues strongly against ACE inhibitor etiology

Assessment / Diagnostic Approach

History

Duration, timing (nocturnal, morning, positional), character (productive vs dry)
Precipitating and relieving factors (allergen exposure, cold air, lying down, meals)
Sense of postnasal drip, throat clearing, heartburn, dyspnea, wheezing
Smoking history and occupational/environmental exposures
Drug history - especially ACE inhibitors, beta-blockers

Physical Examination

Chest auscultation (wheezing, crackles)
External auditory canals and tympanic membranes (Arnold's nerve stimulation)
Nasal passages (rhinitis, polyps, excess secretions)
Posterior pharyngeal wall (cobblestoning suggests postnasal drainage)
Nail clubbing
General examination for systemic disease (sarcoidosis, vasculitis)

Investigations (Step-by-Step)

Step 1 - Chest radiograph (in virtually all cases of chronic cough)

Rules out serious underlying pathology: TB, sarcoidosis, Hodgkin's, lung cancer, heart failure
An abnormal film directs specific further evaluation

Step 2 - Sputum examination (if productive cough)

Gram stain, routine culture
Mycobacterial culture if indicated
Cytology to assess for malignancy, eosinophilic vs neutrophilic bronchitis

Step 3 - Spirometry with flow-volume loop

Detects airflow obstruction (asthma, COPD)
Flow-volume loop can detect vocal cord dysfunction masquerading as asthma

Step 4 - Methacholine provocation test (if spirometry normal but asthma suspected)

Step 5 - CT chest - especially in smokers with cough persisting despite cessation

Step 6 - Specialist referral if cough persists:

Otolaryngologist: laryngoscopy (laryngeal hypersensitivity, vocal cord dysfunction, glottic inflammation)
Gastroenterologist: endoscopy and/or 24-h esophageal pH monitoring
Pulmonologist: bronchoscopy (eosinophilic bronchitis, early malignancy)

Management

Sequential Algorithmic Approach (Tintinalli's Table 62-4)

Obtain chest radiograph if not done
Remove lung irritants (stop smoking); discontinue ACE inhibitors, ARBs, beta-blockers
Treat for postnasal discharge with first-generation antihistamine/decongestant ± intranasal corticosteroid
Evaluate for bronchospasm with spirometry ± methacholine; treat asthma with bronchodilators and inhaled corticosteroids
Treat for GERD with lifestyle changes, H2 blockers, or PPI
CT chest if cough persists (especially smokers)
Specialist referral

Disease-Specific Treatments (Murray & Nadel Table 37.4)

Cause	Treatment
Asthma / Cough-variant asthma	Bronchodilators + inhaled corticosteroids
Eosinophilic bronchitis	Inhaled corticosteroids; leukotriene inhibitors
Allergic rhinitis / Postnasal drip	Topical nasal steroids + antihistamines; topical nasal anticholinergics
GERD	Lifestyle modifications; H2 antagonist or PPI
ACE inhibitor-induced	Discontinue; switch to ARB
Chronic bronchitis / COPD	Smoking cessation; COPD management
Bronchiectasis	Postural drainage; treat infective exacerbations
Infective tracheobronchitis	Antibiotics; treat associated postnasal drip

Note on GERD treatment: Evidence does not support empiric PPI therapy in patients without reflux symptoms. Benefit is more likely in those with documented pathologic acid exposure on pH monitoring or with typical esophageal symptoms (heartburn, regurgitation). - Murray & Nadel's Textbook of Respiratory Medicine

Symptomatic / Antitussive Treatment

Used when specific cause cannot be identified or treated. Reserved for significant quality-of-life impairment.

Non-pharmacologic

Speech and Language Therapy (Speech Pathology Management):

Breathing exercises, cough suppression techniques, vocal and laryngeal hygiene, psychoeducational counseling
Shown to improve cough symptom scores, cough counts, and capsaicin sensitivity
Particularly effective in those with concomitant muscle tension dysphonia or vocal cord dysfunction
Now standard of care in specialized cough clinics

Pharmacologic - Antitussives

Agent	Mechanism	Notes
Codeine	Central (brainstem cough center)	Effective but causes sedation, constipation, dependence
Morphine (slow-release)	Central	Reserved for severe refractory/palliative cough
Dextromethorphan	Central (different site from opioids)	OTC, fewer side effects, less efficacy; can combine with opioids
Benzonatate	Peripheral (inhibits sensory nerve activity)	Variable efficacy; generally free of side effects
Gabapentin / Pregabalin	Neuromodulator	Off-label; useful for cough hypersensitivity syndrome
Amitriptyline	Neuromodulator (TCA)	Off-label; useful for cough hypersensitivity syndrome
Inhaled lidocaine	Peripheral (sodium channel blockade)	Transient only; risk of aspiration due to oropharyngeal anesthesia

Emerging Therapies

Recent evidence supports a promising class of agents: P2X3 receptor antagonists (e.g., gefapixant, sivopixant). A 2024 network meta-analysis confirmed benefit-risk profiles across doses - Yamamoto et al., Chest 2024. These represent a novel approach targeting peripheral sensory nerve sensitization without the dependence risk of opioids.

Other approaches under investigation:

Neurokinin-1 (NK1) receptor antagonists
TRPV1 channel antagonists
Novel opioid-like receptor agonists

Special Considerations

Children

Consider age-specific etiologies: congenital abnormalities (vascular rings, tracheobronchomalacia), pulmonary sequestration, mediastinal tumors, airway foreign bodies, aspiration from swallowing dysfunction, and congenital heart disease. Psychogenic/habit cough is common in children - a throat-clearing noise made by a nervous, self-conscious child - and is a diagnosis of exclusion.

Obstructive Sleep Apnea

OSA can cause nocturnal cough, typically presenting with snoring, nocturnal heartburn, and rhinitis symptoms. CPAP therapy with humidification is usually effective.

Global / Resource-Limited Settings

In TB-endemic regions, chronic cough always mandates evaluation for active pulmonary tuberculosis - chest imaging and sputum analysis. Air pollution (indoor cooking fuels, occupational exposures, outdoor particulates) is a major cause globally; treatment focuses on reducing exposure and use of appropriate face masks. - Harrison's Principles of Internal Medicine 22E (2025)

Summary Flowchart (Narrative)

Chronic cough > 8 weeks
        ↓
Chest X-ray + full history + physical exam
        ↓
Abnormal CXR → Targeted workup (TB, malignancy, sarcoidosis, heart failure)
        ↓
Normal CXR → Step-by-step:
  1. Stop ACE inhibitor / smoking
  2. Treat UACS (antihistamine + nasal steroid)
  3. Treat asthma (ICS + bronchodilator; methacholine challenge if uncertain)
  4. Treat GERD (lifestyle + PPI, only if symptomatic/proven)
  5. CT chest if still unexplained (especially smokers)
  6. Specialist referral (ENT, GI, pulmonology)
  7. Consider cough hypersensitivity syndrome → 
     Speech therapy + gabapentin/amitriptyline/neuromodulators
  8. Refractory → slow-release morphine / P2X3 antagonists

Sources:

Harrison's Principles of Internal Medicine, 22nd Ed. (2025, McGraw Hill), pp. 315-317
Murray & Nadel's Textbook of Respiratory Medicine, 2-Volume Set, Ch. 37
Tintinalli's Emergency Medicine: A Comprehensive Study, Ch. 62

This is a shared conversation. Sign in to Orris to start your own chat.